+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 4871569
  • Report
  • October 2020
  • Region: Global
  • The Business Research Company
Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global drugs for hormonal replacement therapy market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the drugs for hormonal replacement therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drugs For Hormonal Replacement Therapy Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive land scape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive land scape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:
1) By Therapy Type: Estrogen Replacement Therapy; Human Growth Hormone (HGH) Replacement Therapy; Thyroid Replacement Therapy; Testosterone Replacement Therapy
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Hypothyroidism; Male Hypogonadism; Growth Hormone Deficiency; Menopause; Others
4) By Route of Administration: Oral; Parental; Others

Companies Mentioned: Novartis AG; Bayer AG; Pfizer Inc.; Novo Nordisk A/S; Eli Lilly and Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary2. Drugs For Hormonal Replacement Therapy Market Characteristics
3. Drugs For Hormonal Replacement Therapy Market Size And Growth
3.1. Global Drugs For Hormonal Replacement Therapy Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Drugs For Hormonal Replacement Therapy Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Drugs For Hormonal Replacement Therapy Market Segmentation
4.1. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Estrogen Replacement Therapy
  • Human Growth Hormone (HGH) Replacement Therapy
  • Thyroid Replacement Therapy
  • Testosterone Replacement Therapy
4.2. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
4.3. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Menopause
  • Others
4.4. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Route of Administration , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parental
  • Others

5. Drugs For Hormonal Replacement Therapy Market Regional And Country Analysis
5.1. Global Drugs For Hormonal Replacement Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Drugs For Hormonal Replacement Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific Drugs For Hormonal Replacement Therapy Market
6.1. Asia-Pacific Drugs For Hormonal Replacement Therapy Market Overview
6.2. Asia-Pacific Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.4. Asia-Pacific Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
7. China Drugs For Hormonal Replacement Therapy Market
7.1. China Drugs For Hormonal Replacement Therapy Market Overview
7.2. China Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.4. China Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
8. India Drugs For Hormonal Replacement Therapy Market
8.1. India Drugs For Hormonal Replacement Therapy Market Overview
8.2. India Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.4. India Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9. Japan Drugs For Hormonal Replacement Therapy Market
9.1. Japan Drugs For Hormonal Replacement Therapy Market Overview
9.2. Japan Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.4. Japan Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10. Australia Drugs For Hormonal Replacement Therapy Market
10.1. Australia Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.3. Australia Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11. Indonesia Drugs For Hormonal Replacement Therapy Market
11.1. Indonesia Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.3. Indonesia Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12. South Korea Drugs For Hormonal Replacement Therapy Market
12.1. South Korea Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.3. South Korea Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13. Western Europe Drugs For Hormonal Replacement Therapy Market
13.1. Western Europe Drugs For Hormonal Replacement Therapy Market Overview
13.2. Western Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.4. Western Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14. UK Drugs For Hormonal Replacement Therapy Market
14.1. UK Drugs For Hormonal Replacement Therapy Market Overview
14.2. UK Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.4. UK Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15. Germany Drugs For Hormonal Replacement Therapy Market
15.1. Germany Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.3. Germany Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16. France Drugs For Hormonal Replacement Therapy Market
16.5. France Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.6. France Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.7. France Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17. Eastern Europe Drugs For Hormonal Replacement Therapy Market
17.1. Eastern Europe Drugs For Hormonal Replacement Therapy Market Overview
17.2. Eastern Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.4. Eastern Europe Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18. Russia Drugs For Hormonal Replacement Therapy Market
18.1. Russia Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.3. Russia Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19. North America Drugs For Hormonal Replacement Therapy Market
19.1. North America Drugs For Hormonal Replacement Therapy Market Overview
19.2. North America Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.4. North America Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20. USA Drugs For Hormonal Replacement Therapy Market
20.1. USA Drugs For Hormonal Replacement Therapy Market Overview
20.2. USA Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.4. USA Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21. South America Drugs For Hormonal Replacement Therapy Market
21.1. South America Drugs For Hormonal Replacement Therapy Market Overview
21.2. South America Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.4. South America Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22. Brazil Drugs For Hormonal Replacement Therapy Market
22.1. Brazil Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.3. Brazil Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23. Middle East Drugs For Hormonal Replacement Therapy Market
23.1. Middle East Drugs For Hormonal Replacement Therapy Market Overview
23.2. Middle East Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.4. Middle East Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24. Africa Drugs For Hormonal Replacement Therapy Market
24.1. Africa Drugs For Hormonal Replacement Therapy Market Overview
24.2. Africa Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.4. Africa Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
25. Drugs For Hormonal Replacement Therapy Market Competitive Landscape And Company Profiles
25.1. Drugs For Hormonal Replacement Therapy Market Competitive Landscape
25.2. Drugs For Hormonal Replacement Therapy Market Company Profiles
25.2.1. Novartis AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Bayer AG
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Pfizer Inc.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Novo Nordisk A/S
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Eli Lilly and Company
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Drugs For Hormonal Replacement Therapy Market27. Drugs For Hormonal Replacement Therapy Market Trends And Strategies28. Product Pipeline Analysis29. Drugs For Hormonal Replacement Therapy Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer

Executive Summary

Drugs for Hormonal Replacement Therapy market consists of sales of drugs for hormonal replacement therapy and related services. The drugs for hormonal replacement therapy are used to treat patients with growth hormone deficiency caused due to conditions such as dwarfism or menopause (a condition which describes changes a women goes through when her menstruating cycle stops). The drugs for hormonal replacement therapy help to replace low level hormones from the body, maintain growth hormone deficiency and prevent women from vaginal dryness, mood swings, weakening of bones and others.

The global drugs for hormonal replacement therapy market is expected to decline from $15.6 billion in 2019 to $13.2 billion in 2020 at a compound annual growth rate (CAGR) of -15.8%. The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread. Currently there is less demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 3.5% from 2021 and reach $16.9 billion in 2023.

North America was the largest region in the drugs for hormonal replacement therapy market in 2016. This region is expected to remain the largest during the next five years. The drugs for hormonal replacement therapy market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Increasing population of aging and postmenopausal women is driving the drugs for hormonal replacement therapy market growth. Hormonal replacement therapy drugs such as Estrogen, Progestin and others are used to treat medical conditions caused due to menopausal conditions. In 2018, according to a report by The Indian Menopause Society, New Delhi, in India there are 65 million women over the menopausal age affected with menopausal symptoms. According to European Menopause and Andropause Society (EMAS) report, women aged over 60 are expected to reach over 1 billion by 2050. Furthermore, out of the global women population in 2015, 54% of them were aged over 60 and 62% of them were aged over 80. In 2015, in South Korea, the female population is expected to exceed male population by 2060, out of which 59.6% of female population is expected to suffer from postmenopausal symptoms. Thus, growing women population suffering from menopausal symptoms and aging population drives the market for hormonal replacement therapy drugs market.

Increasing occurrence of side effects due to the intake of drugs for hormonal deficiency may hinder growth of drugs for hormonal replacement therapy market. The side effects include vagina dryness, irregular heartbeat, breast swelling, osteoporosis (weakening of bones) and other effects when women undergo hormonal replacement therapy. High dosage of drugs for hormonal replacement therapy may cause rapid heartbeat, bloating (a buildup of gas in the stomach and intestines), nausea, indigestion, vaginal bleeding, blood clots, heart attack, breast cancer and others. In 2017, according to an online study, decrease in the intake of drugs for combined hormone therapy showed a decrease in breast cancer cases by 126,000 and cardiovascular disease cases by 76,000. Thus, the increasing side effects of drugs hinders the growth of drugs for hormonal replacement therapy.

Companies in the industry are increasingly developing of drugs for hormonal replacement therapy with better safety profiles and novel drug delivery mechanisms. The drug delivery mechanisms include transdermal estrogen, varginal estrogen and others. Transdermal estrogen drug delivery is in the form of estradiol transdermal gel, patch, and spray that are used to treat symptoms of menopause, vaginal dryness, itching, burning and others occur due to low estrogen levels. Varginal estrogen in the form of cream, vaginal ring, vaginal tablets are used to get the hormone estrogen into the system. For instance, Novo Nordisk, a multinational pharmaceutical company provides novel drug delivery mechanisms and low dose drugs for hormonal replacement therapy (HRT) to cater to the rising demand of patient needs. Some of the brands offering of novel drugs include Climara, Divigel, Elestrin, Esclim, Estraderm, Estrasorb, EstroGel, Evamist, Oesclim, Rhoxal-Estradiol Derm 50, Vivelle 100 Mcg, Estradot Transdermal Therapeutic System and others.

Department Of Health And Human Services of Food And Drug Administration (FDA), a federal agency, is a regulatory body monitoring, controlling and regulating the drugs for hormonal replacement therapy market. In April 2018, FDA's Department Of Health And Human Services has revised the requirements of specific hormone-containing drug products for human use. These hormones include estrogens, progestin's, androgens, anabolic steroids, adrenal corticosteroids, and synthetic analogs. The purpose of the revisal of existing regulations by FDA is to establish effectiveness and ensure safety for any over-the-counter drug use of these ingredients.

Major players in the market are Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Novartis AG
  • Bayer AG
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Abbott
  • Mylan Laboratories
  • Merck & Co
  • Hisamitsu Pharmaceutical Co Inc
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche
  • Noven Pharmaceuticals;Inc.
  • Orion Pharma AB
  • Allergan Plc
  • QuatRx Pharmaceuticals
  • Wyeth
  • Amgen Inc.
  • Roche
  • Genentech
  • TherapeuticsMD

Methodology

Loading
LOADING...